ロード中...
Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine
The aminosalicylates (5-ASA; also referred to as mesalamine-based agents) are considered as first-line in the maintenance of remission of mild to moderate ulcerative colitis (UC). Traditionally these agents have required a large pill burden and multiple daily dosing regimens which may account for th...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3063115/ https://ncbi.nlm.nih.gov/pubmed/21448448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S5392 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|